SCHEMBL5281643

SCHEMBL5281643

CC(C)(C)OC(=O)N1CCC(CCCNC(=O)COCc2ccc(F)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 16/20 0.49
KDM4E B2RXH2 1/20 0.45
PKM P14618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5279858 0.93 GPR119 (0.44) GPR119
SCHEMBL5287840 0.89 NAMPT (0.41) GPR119
SCHEMBL7871022 0.83 GPR119 (0.49) GPR119
SCHEMBL3358497 0.82 GPR119 (0.50) GPR119KDM4EPKM
SCHEMBL5278232 0.82 CCR1 (0.42) GPR119
SCHEMBL5278229 0.82 CCR1 (0.42) GPR119
SCHEMBL5286937 0.82 CCR1 (0.42) GPR119
SCHEMBL4146238 0.80 GPR119 (0.54) GPR119KDM4EPKM
SCHEMBL5287864 0.80 GPR119 (0.46) GPR119
SCHEMBL5280502 0.79 RAB9A (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP disclosed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 GPR119 1328/4885KDM4E 67/4885PKM 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.